XML 21 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION
3 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
SEGMENT INFORMATION
5.           SEGMENT INFORMATION
 
We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2017.
 
 
 
Three Months Ended
December 31,
 
 
 
2017
 
2016
 
Revenue:
 
 
 
 
 
 
 
Service
 
$
4,525
 
$
5,264
 
Product
 
 
852
 
 
910
 
 
 
$
5,377
 
$
6,174
 
Operating income (loss):
 
 
 
 
 
 
 
Service
 
$
182
 
$
273
 
Product
 
 
(171)
 
 
(179)
 
 
 
$
11
 
$
94
 
 
 
 
 
 
 
 
 
Interest expense
 
 
(52)
 
 
(76)
 
Other income
 
 
 
 
1
 
Income (loss) before income taxes
 
$
(41)
 
$
19